Detalles de la búsqueda
1.
The impact of bridging therapy prior to CD19-directed chimeric antigen receptor T-cell therapy in patients with large B-cell lymphoma.
Br J Haematol
; 195(3): 405-412, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34500492
2.
Chimeric antigen receptor T-cell therapy after allogeneic stem cell transplant for relapsed/refractory large B-cell lymphoma.
Br J Haematol
; 192(1): 212-216, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33169845
3.
Disparities in black and white patients with multiple myeloma referred for autologous hematopoietic transplantation: a single center study.
Cancer
; 121(7): 1064-70, 2015 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25469920
4.
Single center experience with total body irradiation and melphalan (TBI-MEL) myeloablative conditioning regimen for allogeneic stem cell transplantation (SCT) in patients with refractory hematologic malignancies.
Ann Hematol
; 93(4): 653-60, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24097082
5.
Rapid relapse of large B-cell lymphoma after CD19 directed CAR-T-cell therapy due to CD-19 antigen loss.
Am J Hematol
; 94(10): E273-E275, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31342556
6.
Refractory postallogeneic stem cell transplant pure red cell aplasia in remission after treatment with daratumumab.
Am J Hematol
; 94(8): E216-E219, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31120638
7.
Outcomes of Busulfan, Fludarabine, and 400 cGy Total Body Irradiation Compared With Busulfan and Fludarabine Reduced-Intensity Conditioning Regimens for Allogeneic Stem Cell Transplantation in Adult Patients With Hematologic Diseases: A Single-Center Experience.
Transplant Proc
; 55(1): 214-224, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36635141
8.
Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer.
Nat Med
; 11(11): 1230-7, 2005 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-16227990
9.
Immune effector cell-associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy for lymphoma: predictive biomarkers and clinical outcomes.
Neuro Oncol
; 23(1): 112-121, 2021 01 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-32750704
10.
Phase I trial of first-line bortezomib/thalidomide plus chemotherapy for induction and stem cell mobilization in patients with multiple myeloma.
Clin Lymphoma Myeloma
; 7(3): 210-6, 2006 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17229337
11.
Combination immunotherapy after ASCT for multiple myeloma using MAGE-A3/Poly-ICLC immunizations followed by adoptive transfer of vaccine-primed and costimulated autologous T cells.
Clin Cancer Res
; 20(5): 1355-65, 2014 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24520093
12.
Rapid immune recovery and graft-versus-host disease-like engraftment syndrome following adoptive transfer of Costimulated autologous T cells.
Clin Cancer Res
; 15(13): 4499-507, 2009 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19509133
Resultados
1 -
12
de 12
1
Próxima >
>>